Foreign Direct Investment Advisory
Foreign direct investment into and out of the United States now carries national-security review and counterparty risk that standard financial and legal due diligence often miss. Artisan Business Group helps investors, acquirers, and U.S. targets assess CFIUS exposure, determine filing requirements, navigate the review process — and vet the counterparties behind the deal.
The Problem
The Committee on Foreign Investment in the United States (CFIUS) reviews foreign acquisitions and investments for national-security risk, and transactions with Chinese nexus face intense scrutiny — review can block or unwind a deal, impose mitigation conditions that change its economics, or trigger months of uncertainty. At the same time, the risks that sink cross-border deals are rarely in the financial statements: undisclosed beneficial ownership, export-control or sanctions history, reputation issues, and governance structures that protect one side's interests at the other's expense. Standard financial due diligence and law-firm background checks often lack the regional expertise, language capability, and government-record access to surface these issues before close.
How We Help
- CFIUS jurisdiction analysis — determining whether a transaction triggers review and whether filing is mandatory or voluntary
- National-security risk assessment — identifying the specific sensitivities CFIUS will examine
- Filing strategy — recommending whether to file voluntarily before close or proceed and monitor
- Transaction structuring — advising on deal structures that reduce CFIUS exposure
- Mitigation strategy — preparing for likely mitigation conditions (security agreements, board restrictions)
- Beneficial ownership research — tracing the ultimate beneficial owners of Chinese and Asian corporate counterparties
- Regulatory history review — identifying export-control, sanctions, customs, and procurement violations
- Reputation and integrity assessment — evaluating principals and key executives across Chinese and English-language sources
- Governance and related-party analysis — reviewing board structure, related-party transactions, and minority-shareholder protections
Our Process
Jurisdiction Screen
Determine whether the transaction is covered by CFIUS and whether filing is mandatory under FIRRMA.
Risk & Counterparty Profile
Identify the national-security sensitivities and trace beneficial ownership, regulatory history, and reputation of the counterparty and its principals.
Filing Strategy
Recommend the optimal filing path: voluntary notice, short-form declaration, or proceed without filing.
Submission & Structuring Support
Assist in coordinating with legal counsel on filing preparation and advise on deal structures that reduce CFIUS exposure.
Mitigation Preparation
Prepare clients for likely conditions and deliver a red-flag report with risk ratings and recommendations.
Who This Is For
- Chinese and Asian investors acquiring or investing in U.S. companies
- U.S. companies accepting foreign investment or being acquired by foreign buyers
- Private equity and venture capital funds with foreign limited partners investing in sensitive U.S. sectors
- Family offices making cross-border investments in technology, infrastructure, or real estate near sensitive facilities
- U.S. companies acquiring or partnering with Chinese or Asian counterparties
- Boards and audit committees reviewing related-party transactions in cross-border companies
- Lenders assessing counterparty risk in cross-border financings
Frequently Asked Questions
What transactions trigger a mandatory CFIUS filing?
Since FIRRMA (2018), mandatory declarations are required for foreign government-controlled investments in any U.S. business, and for certain foreign investments in U.S. TID businesses — those involving critical Technologies, critical Infrastructure, or sensitive personal Data. The TID categories are broad: semiconductor design and manufacturing, AI, biotech, advanced energy, telecommunications infrastructure, and any company with access to U.S. government personal data. Mandatory declarations must be filed no later than 30 days before the expected close date.
What triggers a CFIUS review of a Chinese-linked acquisition?
CFIUS scrutinizes any investment where a Chinese person or entity — including funds with Chinese limited partners — would gain control of or certain minority rights in a U.S. business. Beyond control, CFIUS reviews investments that give a foreign person access to material nonpublic technical information, board or observer rights, or involvement in substantive decision-making. Even passive investments below the typical thresholds can trigger review if the U.S. business is in a sensitive sector. CFIUS has also scrutinized transactions structured to obscure Chinese beneficial ownership.
What red flags in cross-border partner vetting do most buyers miss?
The most commonly missed red flags: (1) shell-company beneficial ownership — the nominal counterparty is a BVI or Cayman entity with undisclosed Chinese state or party-linked beneficial owners; (2) undisclosed CFIUS-reportable ownership; (3) Entity List or SDN adjacency — a principal or affiliate closely associated with a designated entity; (4) domestic Chinese litigation or administrative violations that require Chinese-language database access to surface; and (5) political-exposure issues. Standard Western background checks miss most of these.
How do you research beneficial ownership for Chinese companies?
Chinese corporate ownership research requires accessing the National Enterprise Credit Information Publicity System, local Administration for Market Regulation registries, and for larger companies, SAMR records. These disclose registered shareholders, legal representatives, and branch establishments, but beneficial ownership is frequently obscured through multi-tier holding structures — particularly where the ultimate owner is a state-owned enterprise, a politically exposed person, or a foreign investor seeking anonymity. Effective research traces ownership through each layer, cross-references offshore vehicles, and identifies anomalies between the legal structure and the operational relationship.
What is successor liability in a cross-border acquisition?
Successor liability means the acquiring company inherits the legal obligations and liabilities of the target — including regulatory violations that occurred before the acquisition. In cross-border deals, the most significant successor liability risks are export-control violations that create BIS or OFAC liability for the buyer, customs violations (including UFLPA-related ones) that carry CBP penalty exposure, and tax liabilities in Chinese subsidiaries. Successor liability cannot always be fully negotiated away through contractual representations and warranties — and in export-control cases, voluntary self-disclosure by the buyer after discovering a prior violation is often the most effective risk-management tool.
Can CFIUS review a deal that already closed?
Yes. CFIUS has authority to review completed transactions — and if it determines a national-security risk exists, it can require divestiture. Since 2018, CFIUS has been more aggressive in reviewing non-notified deals, particularly those involving Chinese investors in sensitive technology companies. A closed transaction without a CFIUS filing is not necessarily safe; CFIUS can self-initiate a review if it learns of a covered transaction. This is one reason voluntary filings remain strategically important even when mandatory filing does not apply.
How long does a CFIUS review or a cross-border due diligence take?
A CFIUS declaration takes 30 days; a full voluntary notice takes 45 days (initial review) plus up to 45 days for investigation and 15 days for presidential action. In practice, most deals that receive clearance do so within 60–75 days. For due diligence, a standard partner-vetting report for a single counterparty takes two to three weeks; full transaction due diligence for a complex acquisition typically takes four to eight weeks depending on scope and access to records. We scope engagements to match deal timelines.
Related Insights
Don't navigate this exposure alone.
Get a confidential, firsthand read from Brian B. Su — and a clear next step.
Book a ConsultationRelated Services
Engagements available as Intelligence Briefs, Project Engagements, or Retained Advisory. See how we work →
